- Sep 21, 2016
- 1,051
- Tinnitus Since
- 2011 - T, 2016- H, relapsed 2019
- Cause of Tinnitus
- noise-induced
My reply here is a bit belated but yes you're right - all the Nav 1.7 drugs are in pre-clinical development - I think Navega intends to start clinical trials in a year or two, however, which could expand the scope for compassionate use etc.As far as I know, there aren't any current drugs available that act on these channels.
@serendipity1996 would be another person to ask.
There have been companies (Biogen for one) that have tried but pulled out because the drugs weren't specific enough and there was activity at other related ion channels (the Trobalt problem, basically).
You can still get a lab to make some of these compounds but I really wouldn't go that route, personally, as there was obviously reasons to abandon the drug (it's also less effective when the drug is less selective, too, in addition to more side effects).
This company has a different approach though:
https://navegatx.com/en
They are using epigenetics to switch on/off the receptor and it has a lot more specificity. Maybe you could contact them and ask about trials (I think it would be too early for compassionate use, I think you might have to have done a Phase 1 first).
Here is their recently published paper:
https://stm.sciencemag.org/content/13/584/eaay9056
I wouldn't say my noxacusis is extreme. The pain is persistent but more moderate but one thing that does help me is lots of liquid Magnesium chloride (the oral formulation, not the topical).
If I recall correctly (could be thinking of someone else), you were weaning off of Benzos. Make sure you get a specialist to help with that, if so (i.e. someone familiar with the Ashton protocol). People tend to get better otologic symptoms once that nightmare is better.
From what I have read, lack of specificity was one of the initial hurdles and there's definitely been progress on this but I think Xenon and Navega are companies to keep an eye on.